Research Keyword: posaconazole

Fungal Pneumonia and Severe Neutropenia: Risk Factors for Increased 90 Day Mortality

mycolabadmin

This study examined 39 cancer patients with severe fungal lung infections treated at a major cancer center. Patients who received antifungal treatment within 7 days and started with a specific drug called liposomal amphotericin B had better survival rates at 90 days. The research suggests that quick diagnosis and prompt treatment initiation are critical for improving survival in immunocompromised patients with fungal pneumonia.

Read More »

Continuous debridement combined with short-term posaconazole therapy for cutaneous mucormycosis caused by Rhizopus oryzae infection secondary to acute myeloid leukemia: a case report

mycolabadmin

An 80-year-old patient with acute myeloid leukemia developed a serious fungal skin infection caused by Rhizopus oryzae on his lower leg. Doctors treated the infection by repeatedly cleaning out the infected tissue and giving him an antifungal medication called posaconazole for just one week. Despite the short treatment duration due to cost concerns, the patient’s wound gradually healed over four months through continued surgical care, showing that sometimes focused surgical treatment can be as effective as long-term medication.

Read More »

Cutaneous Mucormycosis Following Polytrauma: A Multidisciplinary Approach

mycolabadmin

A 22-year-old man suffered severe injuries from a motorcycle-truck collision that damaged his perineal area and left thigh. Despite antibiotics and wound therapy, a dangerous fungal infection called mucormycosis developed in the wound. The medical team treated this by repeatedly removing infected tissue, using powerful antifungal medications (amphotericin B and posaconazole), and carefully managing the wound with special therapy before skin grafting, ultimately achieving successful healing.

Read More »

The first described case of Fomitiporella micropora infection in humans: A heart transplant recipient diagnosed by fungal PCR

mycolabadmin

A heart transplant patient developed a slow-growing lump on his shin that turned out to be caused by a rare fungus never before seen in humans. Doctors removed the lump surgically and used advanced genetic testing to identify the unusual fungus as Fomitiporella micropora. The patient received antifungal medication and the wound healed completely, highlighting how modern genetic tests can identify rare infections that traditional methods might miss.

Read More »

The first described case of Fomitiporella micropora infection in humans: A heart transplant recipient diagnosed by fungal PCR

mycolabadmin

A patient who received a heart transplant developed a small, slowly-growing lump on his shin over many years. After surgical removal, genetic testing revealed it was caused by a rare fungus never before identified in humans. The surgical removal likely cured the infection, and the case shows how important advanced genetic testing methods are for identifying unusual infections in transplant patients.

Read More »
Scroll to Top